The enormous research progress in autoimmune disorders makes the establishment of long‐
term clinical tolerance to autoantigens an accessible goal. This strategy endows lymphoid …

Purpose. One of the biggest challenges in cancer immunotherapy is generating robust
cancer‐specific immunity. This work describes using a biocomplex assembled from a toll …

Tendon injuries are at the frontier of innovative approaches to public health concerns and
sectoral policy objectives. Indeed, these injuries remain difficult to manage due to tendon's …

Rheumatoid arthritis (RA) is a systemic autoimmune disease featured by skewed immunity
that can cause joint inflammation and cartilage destruction. Existing clinical therapeutic …

Chronic autoimmune disorders collectively affect 5-7% of the global population and are a
major public health concern. The prevailing paradigm for autoimmune disease treatment …

Over the past few decades, regulatory T cell (Treg) therapy has gained traction for the
treatment of autoimmunity, transplant rejection, and other inflammatory diseases. A …

Type 1 diabetes, also known as autoimmune diabetes or insulin-dependent diabetes, is a
chronic disease that mostly affects children and young people. This pathology is marked by …

Immune dysregulation and difficulties in directing immune function in cancer and
autoimmune disease pose complex challenges for existing vaccines and immunotherapies …

................................. Biomaterials for Localized Drug Delivery in VCA..........................................
Future of Biomaterials and Immunotherapy in Reconstructive Transplantation …

Conventional systemic immunomodulation still remains the biggest hurdle in the field of
reconstructive transplantation, preventing its global acceptance. The prolonged …